There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Blueprint Medicines (BPMC), ANI Pharmaceuticals (ANIP) and Progenity (PROG) with bullish sentiments.
Blueprint Medicines (BPMC)
In a report released today, Dane Leone from Raymond James maintained a Buy rating on Blueprint Medicines, with a price target of $122.00. The company’s shares closed last Wednesday at $100.25.
According to TipRanks.com, Leone is a 5-star analyst with an average return of 19.8% and a 66.1% success rate. Leone covers the Healthcare sector, focusing on stocks such as Tarsus Pharmaceuticals, Allogene Therapeutics, and Ayala Pharmaceuticals.
Blueprint Medicines has an analyst consensus of Moderate Buy, with a price target consensus of $120.57.
See today’s analyst top recommended stocks >>
ANI Pharmaceuticals (ANIP)
In a report released today, Elliot Wilbur from Raymond James maintained a Buy rating on ANI Pharmaceuticals. The company’s shares closed last Wednesday at $31.00.
According to TipRanks.com, Wilbur is a 1-star analyst with an average return of -0.3% and a 48.2% success rate. Wilbur covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Amneal Pharmaceuticals, and Flexion Therapeutics.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for ANI Pharmaceuticals.
Progenity (PROG)
Raymond James analyst Andrew Cooper maintained a Buy rating on Progenity today. The company’s shares closed last Wednesday at $5.70.
According to TipRanks.com, Cooper is a 4-star analyst with an average return of 42.4% and a 85.7% success rate. Cooper covers the Healthcare sector, focusing on stocks such as Orasure Technologies, Idexx Laboratories, and GenMark.
Progenity has an analyst consensus of Moderate Buy, with a price target consensus of $7.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
